Aim Immunotech INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersOcala, FL
US patents5
SAM.gov UEIJD13ZJQWB8W5
CAGE code9J7R8
Incorporated inDE
Brands
AIM Carousel Assets_Disease Areas
AIM Carousel Assets_Programs
AIM Carousel Assets_PartnersThis company sells these brands.
- clinical studies
- working
- therapeutic solutions
- immune disorders
Named on the company’s own website, read JUL 29, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
5 US patents granted 2023–2025, 5 of them in the five years to SEP 2025.
Pharmaceuticals 5
- Therapeutic double stranded RNA and methods for producing the sameUS 12,312,376 · granted MAY 27, 2025
- Methods and compositions for treating endometriosisUS 12,102,649 · granted OCT 1, 2024
- Methods for improving exercise tolerance in myalgic encephalomyelitis patientsUS 11,813,281 · granted NOV 14, 2023
- Compositions for cancer therapy and methodsUS 11,813,279 · granted NOV 14, 2023
- Method of reducing antigenic drift or reassortment of viruses in a host animal using α interferonUS 11,642,396 · granted MAY 9, 2023
Granted to AIM ImmunoTech Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Aim Immunotech INC. | Ocala | FL | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.